Tiziana Life Sciences (TLSA) announced that its CEO Ivor Elrifi, has purchased 193,848 shares of Tiziana common stock at a price of $1.65 per share in the open market.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Chairman Increases Stake with Recent Share Purchase
- Tiziana Life Sciences announces purchase of shares by chairman
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
- Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
- FDA Approves Tiziana Life Sciences’ Phase 2a Trial for MSA